Literature DB >> 6802762

Gonococci with mutations to low-level penicillin resistance exhibit increased sensitivity to the oxygen-independent bactericidal activity of human polymorphonuclear leukocyte granule extracts.

J A Daly, T J Lee, J K Spitznagel, P F Sparling.   

Abstract

Gonococci which cause disseminated gonococcal infection are nearly always highly penicillin sensitive, in contrast to many isolates causing uncomplicated gonorrhea. We questioned whether any of the known chromosomal mutations to low-level penicillin resistance might adversely affect virulence. The penA2 locus is known to result in low-level resistance to penicillins, whereas mtr-2 results in nonspecific resistance to a variety of antimicrobial agents. We found that the penA2 and mtr-2 mutations each markedly increased sensitivity of strain FA19 to oxygen-independent killing by human polymorphonuclear leukocyte mixed or isolated azurophilic granule extracts. The penA2 and mtr-2 mutations had no effect on sensitivity to serum antibody and complement. Isogenic opaque or transparent variants of several strains of Neisseria gonorrhoeae were equally resistant to human polymorphonuclear leukocyte mixed granule extract bactericidal systems. There were also no differences in susceptibility of piliated type 1 and nonpiliated type 4 variants to human polymorphonuclear leukocyte mixed granule extracts. Since the penA2 and mtr-2 loci are known to increase the degree of cross-linking of cell wall peptidoglycan, the structure of peptidoglycan apparently affects sensitivity to killing by one or more polymorphonuclear leukocyte azurophilic granule extract bactericidal systems. These observations might explain why gonococci with mutations similar to penA2 and mtr-2 are almost never isolated from patients with disseminated gonococcal infection.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802762      PMCID: PMC351122          DOI: 10.1128/iai.35.3.826-833.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Myeloperoxidase-mediated iodination in granulocytes.

Authors:  I Olsson; T Olofsson; H Odeberg
Journal:  Scand J Haematol       Date:  1972

2.  Phagocytosis of mutants of Salmonella typhimurium by rabbit polymorphonuclear cells.

Authors:  O Stendahl; L Edebo
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1972

3.  Intraphagosomal pH of human polymorphonuclear neutrophils.

Authors:  G L Mandell
Journal:  Proc Soc Exp Biol Med       Date:  1970-06

4.  The sensitivity of smooth and rough gram-negative bacteria to the immune bactericidal reaction.

Authors:  L H Muschel; L J Larsen
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

5.  Association of lactoferrin with lysozyme in granules of human polymorphonuclear leukocytes.

Authors:  M S Leffell; J K Spitznagel
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Analyses of lipopolysaccharides extracted from penicillin-resistant, serum-sensitive salmonella mutants.

Authors:  B W Nelson; R J Roantree
Journal:  J Gen Microbiol       Date:  1967-08

8.  Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro.

Authors:  D S Kellogg; I R Cohen; L C Norins; A L Schroeter; G Reising
Journal:  J Bacteriol       Date:  1968-09       Impact factor: 3.490

9.  Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Authors:  E F Osserman; D P Lawlor
Journal:  J Exp Med       Date:  1966-11-01       Impact factor: 14.307

10.  Cell wall composition and virulence in Escherichia coli.

Authors:  D N Medearis; B M Camitta; E C Heath
Journal:  J Exp Med       Date:  1968-09-01       Impact factor: 14.307

View more
  11 in total

Review 1.  The Jeremiah Metzger Lecture. Microbial defenses against killing by phagocytes.

Authors:  G L Mandell; M O Frank
Journal:  Trans Am Clin Climatol Assoc       Date:  1992

2.  Characterization of a protein from normal human polymorphonuclear leukocytes with bactericidal activity against Pseudomonas aeruginosa.

Authors:  C J Hovde; B H Gray
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

3.  Antigonococcal activity of human neutrophil cathepsin G.

Authors:  W M Shafer; V C Onunka; L E Martin
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 4.  Interactions of Neisseria gonorrhoeae with human neutrophils.

Authors:  R F Rest; W M Shafer
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  Effects of human serum on bacterial competition with neutrophils for molecular oxygen.

Authors:  B E Britigan; M S Cohen
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

Review 6.  Virulence versus resistance.

Authors:  K M Krasinski
Journal:  Bull N Y Acad Med       Date:  1987-04

7.  Netherlands Society for Microbiology, Medical Section and Netherlands Association of Laboratory Physicians, joint meeting. Rotterdam, 10 November 1983. Abstracts.

Authors: 
Journal:  Antonie Van Leeuwenhoek       Date:  1985       Impact factor: 2.271

8.  Outer membrane permeability of Acinetobacter calcoaceticus mediates susceptibility to rat polymorphonuclear leukocyte granule contents.

Authors:  M J Loeffelholz; M C Modrzakowski
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

9.  Neisseria gonorrhoeae survive intraleukocytic oxygen-independent antimicrobial capacities of anaerobic and aerobic granulocytes in the presence of pyocin lethal for extracellular gonococci.

Authors:  S G Casey; W M Shafer; J K Spitznagel
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

10.  Anaerobiosis increases resistance of Neisseria gonorrhoeae to O2-independent antimicrobial proteins from human polymorphonuclear granulocytes.

Authors:  S G Casey; W M Shafer; J K Spitznagel
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.